Translate • Sign in • JOIN

This Community is Archived.

All content of the community is available for reading, searching, and recommending, and the list of community members has been saved. No new content can be posted to the community via GHDonline.org or via email and no email notifications will be sent for the archived community. Members can neither join nor leave the archived community.

Moderators of Adherence & Retention and GHDonline staff

Recommend
0
| More

Impact of metabolic complications on ART adherence: clinical and public health implications

Started by Jean Nachega, MD, PhD on 21 Sep 2009
Last edited by Robert Szypko on 03 Aug 2011

Dear Colleagues: Last month, colleagues and I published a review paper entitled "Impact of metabolic complications on antiretroviral treatment adherence: ...

Members-only Content
The full text of this discussion is only available to members of the [ARCHIVED] Adherence & Retention community on GHDonline. Registration for GHDonline is simple and is provided free of charge -- sign up now. If you are already a member, sign in to view this discussion.

Discussion Brief

Following the post of the abstract “Impact of metabolic complications on antiretroviral treatment adherence: clinical and public health implications” by moderator Jean Nachega, members share their experiences addressing patient adherence challenges related to the chronic side effects of Antiretroviral therapy (ART).
Sign in to read complete brief

Related content from other Communities

Resources
Discussions